Get the Daily Brief
Latest Biotech News
mRNA Vaccine Funding Cuts and National Security Implications
The U.S. Department of Health and Human Services (HHS), under Secretary Robert F. Kennedy Jr., has ceased nearly $500 million in funding for mRNA vaccine development through the Biomedical...
Advances in Protein Evolution Techniques
A transformative platform named T7-ORACLE has been developed by researchers at Scripps Research Institute to accelerate directed protein evolution inside living cells. Leveraging an orthogonal T7...
Biopharma Financing Trends and Industry Fundraising
Biopharmaceutical fundraising in 2025 shows a nuanced landscape characterized by a total of approximately $34.89 billion raised through various financing mechanisms in the first seven months,...
New Clinical Approvals and Regulatory Updates in Oncology and Infectious Diseases
Recent regulatory developments have advanced therapeutic options in oncology and infectious diseases. The FDA has granted accelerated approval to Boehringer Ingelheim’s oral targeted therapy...
Innovations in Hydrogel and Biomaterial Design
Cutting-edge research leverages artificial intelligence and bioinspiration to engineer advanced hydrogels with superior adhesive properties. Inspired by marine organisms such as barnacles and...
Neurodegenerative Disease Research Advances
Recent breakthroughs illuminate pivotal mechanisms and potential therapies targeting neurodegenerative disorders. Harvard Medical School researchers demonstrated reversal of Alzheimer's pathology...
AI and Computational Innovations in Single-Cell and Genomic Analysis
Significant technological advancements have been achieved in the integration of artificial intelligence with genomics and single-cell biology. 10x Genomics announced the acquisition of Scale...
Obesity and Metabolic Disease Therapeutics Landscape
The competitive landscape for obesity treatments evolves amid mixed clinical results and market dynamics. Eli Lilly's oral GLP-1 agonist, orforglipron, demonstrated weight loss efficacy up to...
AI in Battery and Energy Storage Management
Innovations integrating artificial intelligence and advanced materials have significantly improved lithium-ion battery performance and longevity prediction. Researchers have developed hybrid deep...
HHS ends mRNA vaccine funding amid scientific backlash
The U.S. Department of Health and Human Services (HHS), under Secretary Robert F. Kennedy Jr., has terminated nearly $500 million in contracts dedicated to developing mRNA vaccines for infectious...
Strand Therapeutics raises $153M for programmable mRNA cancer drugs
Strand Therapeutics, a Cambridge-based biotech specializing in programmable mRNA therapies designed to activate immune responses against solid tumors, secured a $153 million Series B financing....
Eli Lilly's oral GLP-1 obesity pill underperforms rivals in phase 3 trial
Eli Lilly reported top-line results from the Attain-1 phase 3 trial of orforglipron, its oral GLP-1 receptor agonist for obesity treatment. The highest dose resulted in an average weight loss of...
10x Genomics acquires Scale Biosciences to scale single-cell tech
10x Genomics announced its acquisition of Scale Biosciences, a company specializing in instrumentation-free, high-throughput combinatorial barcoding technologies for single-cell analysis. The...
Major biopharma financings highlight investment trends
Several biopharma companies have announced significant funding rounds and financings amid an otherwise downturn in sector-wide investment activity. Notable deals include Frazier Life Sciences...
Pediatric and neonatal care innovations advance with new diagnostics and therapies
Pediatric and neonatal medicine have seen critical advances ranging from novel imaging technologies to therapeutic regimens. Notable developments include Boston Children’s Hospital, Dana-Farber,...
Cancer drug developments and clinical trials show promising progress
Recent oncology updates reveal a dynamic landscape of drug development and clinical trial advances. Highlights include AbbVie and Genmab’s Phase 3 success for the T cell engager Epkinly in...
Advances in battery and energy storage technologies push performance frontiers
Cutting-edge research in battery sciences and energy storage is marking significant progress. Innovations include deep eutectic electrolyte use to stabilize aluminum anodes, bimetallic doping...
Neuroscience research unveils new insights into brain development and neurodegeneration
Recent neuroscience studies investigate fundamental mechanisms in brain development and neurodegenerative diseases. Breakthroughs include microglia’s regulation of prenatal neurogenesis via IGF1...
mRNA vaccine funding cuts: National security concerns rise
The U.S. Department of Health and Human Services (HHS), led by Secretary Robert F. Kennedy Jr., has abruptly terminated nearly $500 million in contracts supporting 22 mRNA vaccine development...
Obesity drug market heats up amid trial results and competition
Recent data highlight a complex competitive landscape in anti-obesity pharmaceuticals. Eli Lilly’s oral GLP-1 agonist orforglipron reported weight loss around 11% after 72 weeks, falling short of...